TWST Twist Bioscience Corporation

111.62USD-4.07%Mkt Cap: 7.61B USDP/E: —

Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. It offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agricult…

Insiders, last 90 daysNet sellers
Institutional holders20 on file

Key Statistics

Company
Market Cap7.61B USD
Enterprise Value7.46B USD
Revenue (TTM)459.43M USD
Gross Profit191.00M USD
Net Income (TTM)-77.67M USD
Revenue/Share7.34 USD
Last Price111.62 USD
Fiscal Year EndSep 2026
MR QuarterSep 2026
Employees—
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)1708.56
PEG—
EV/EBITDA-67.78
EV/Revenue16.24
P/S16.56
P/B8.52
EPS (TTM)-2.23 USD
EPS (Forward)-0.40 USD
52W Range
23.3045% of range219.71
52W High219.71 USD
52W Low23.30 USD
Profitability
Gross Margin50.72%
Oper. Margin-28.79%
EBITDA Margin-23.39%
Profit Margin-20.63%
ROE-16.42%
ROA-12.10%
ROIC-43.11%
ROCE-24.75%
Growth
Revenue Growth27.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-47.63M USD
CapEx (TTM)28.00M USD
FCF Margin—
FCF Yield—
Net Debt-471.92M USD
Net Debt/EBITDA4.39
Net Debt/FCF—
Balance Sheet
Debt/Equity0.16
Current Ratio5.86
Quick Ratio5.18
Book Value/Sh7.11 USD
Cash/Share8.92 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.9 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)128.92 USD
Upside (mean)+15.5%
Target Range45.00 USD – 175.00 USD
45.00+15.5% to mean175.00
# Analysts12
Ownership
Shares Out.66.30M
Float64.39M
Insiders0.90%
Institutions121.28%
Short Interest
Short Ratio3.3d
Short % Float18.71%
Short % Out.14.83%
Shares Short9.84M
Short (prev mo.)10.57M
Technical
SMA 50149.83 (-25.5%)
SMA 20093.56 (+19.3%)
Beta2.22
S&P 52W Chg12.08%
Avg Vol (30d)2.43M
Avg Vol (10d)2.59M
Technical Indicators
RSI (14)40.3
MACD-10.4954
MACD Signal-8.4643
MACD Hist.-2.0311
BB Upper173.80 USD
BB Middle132.95 USD
BB Lower92.09 USD
BB Width61.46%
ATR (14)15.41 USD
Vol Ratio (20d)0.92x

About Twist Bioscience (NASDAQ: TWST)

›

Twist Bioscience (NASDAQ: TWST) is listed on Nasdaq, where its shares trade in USD. It belongs to the Biotechnology industry, part of the Healthcare sector.

The shares were at 111.62 USD on 19 November 2026, up 254.1% over 52 weeks. Its 52-week range is 23.30 USD to 219.71 USD: the price is 49.2% below the high and 379.1% above the low.

Its market capitalisation is 7.61B USD.

Twist Bioscience reports return on equity of -16.4%, an operating margin of -28.8% and revenue up 27.9% year over year.

It holds more cash than debt, a net cash position of 471.92M USD. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. 12 analysts cover the stock, with an average rating of Buy; their mean price target of 128.92 USD is 15.5% above the current price.